Permethrin and Genvoya drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Permethrin (permethrin) and Genvoya (cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate). Common drug interactions include anhedonia among females and anhedonia among males.
The phase IV clinical study analyzes what interactions people have when they take Permethrin and Genvoya. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.
What is Permethrin?
Permethrin has active ingredients of permethrin. It is often used in scabies. eHealthMe is studying from 1,547 Permethrin users. Check the latest studies of Permethrin.
What is Genvoya?
Genvoya has active ingredients of cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 13,538 Genvoya users. Check the latest studies of Genvoya.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
17 people who take Permethrin and Genvoya together, and have interactions are studied.

What are the common drug interactions of Permethrin and Genvoya, by gender? *:
female:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Bone pain
- Decreased activity
- Depression
- Emotional distress
- Fear
- Malaise (a feeling of general discomfort or uneasiness)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Pain
male:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Depression
- Osteoporosis (bones weak and more likely to break)
- Quality of life decreased
- Renal failure (kidney dysfunction)
- Tooth loss
- Ankle fracture
- Arthralgia (joint pain)
- Asthenia (weakness)
What are the common drug interactions of Permethrin and Genvoya, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Acarodermatitis (skin inflammation caused by mites (acarids))
- Hand-foot-and-mouth disease
- Rash vesicular (rash with a small bubble)
30-39:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Emotional distress
- Pain
- Back pain
- Bone density decreased
- Decreased activity
- Depression
- Osteopenia (a condition where bone mineral density is lower than normal)
- Quality of life decreased
40-49:
- Anxiety
- Emotional distress
- Pain
- Blood creatinine increased
- Bone density decreased
- Bone pain
- Decreased activity
- Depression
- Fear
- Hip arthroplasty
50-59:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Emotional distress
- Pain
- Renal failure (kidney dysfunction)
- Renal injury (kidney injury)
- Fracture
60+:
n/a
What are the existing conditions these people have? *
- Pain: 4 people, 23.53%
- Quit Smoking: 2 people, 11.76%
- Peripheral Swelling: 2 people, 11.76%
- Nausea (feeling of having an urge to vomit): 2 people, 11.76%
- Irritable Bowel Syndrome: 2 people, 11.76%
- Hypersensitivity: 2 people, 11.76%
- High Blood Pressure: 2 people, 11.76%
- High Blood Cholesterol: 2 people, 11.76%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.76%
- Constipation: 2 people, 11.76%
* Approximation only. Some reports may have incomplete information.
Do you take Permethrin and Genvoya?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Permethrin (1,547 reports)
- Genvoya (13,538 reports)
Browse all drug interactions of Permethrin and Genvoya:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Permethrin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Genvoya:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Permethrin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Genvoya and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on permethrin and cobicistat; elvitegravir; emtricitabine; tenofovir alafenamide fumarate (the active ingredients of Permethrin and Genvoya, respectively), and Permethrin and Genvoya (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Azelastine and Memory Impairment for Men aged 60+ - 7 seconds ago
- Azelastine and Memory Aids for Men aged 60+ - 7 seconds ago
- Azelastine and Long-Term Memory Loss for Men aged 60+ - 8 seconds ago
- Azelastine and Sudden Memory Loss for Men aged 60+ - 8 seconds ago
- Azelastine and Temporal Memory Loss for Men aged 60+ - 8 seconds ago
- Azelastine and Short-Term Memory Loss for Men aged 60+ - 9 seconds ago
- Azelastine and Loss Of Memory for Men aged 60+ - 9 seconds ago
- Azelastine and Impaired Memory for Men aged 60+ - 9 seconds ago
- Azelastine and Forgetfulness for Men aged 60+ - 9 seconds ago
- Azelastine and Amnesia for Men aged 60+ - 10 seconds ago